As happens in a patient with severe COVID-19, there is reprogramming of glucose metabolism, associated with increased expression of the ubiquitous sodium-independent glucose transporter 1 (glut1) in immune and non-immune cells, increased expression of glycolytic enzymes which contributes to the increase in glucose uptake [47]. The gene discussed is SLC2A1; the disease is COVID-19.